Companies Cryptocurrencies
Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp
Exchange: NasdaqGS
IPO Date: 10/05/2012
CEO: Dr. Gerrit Dispersyn
Biotechnology Healthcare đź”—
  • PHIO
  • 0.711
  • 9711336
    market cap
  • 0.00350004
If you bought

shares of Phio Pharmaceuticals Corp (PHIO) on
You would have made
Old Price $12 Current Price $12

Phio Pharmaceuticals Corp, formerly RXi Pharmaceuticals Corporation, is a biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) (sd-rxRNA) therapeutic platform. The Company’s focuses on developing sd-rxRNA therapeutic compounds to be used in the context of adoptive cell transfer by targeting checkpoints or other gene targets, or to be used in immunotherapy following intratumoral injection. The Company’s pipeline include RXI-762 and RXI-804. Its sd-rxRNA compounds are designed to down-regulate the expression of a specific gene that may be over-expressed in a disease condition. The Company is developing RXI-762 for the treatment of Melanoma, Ovarian cancer and other indications. RXI-804 is an sd-rxRNA compound that is designed to suppress the expression of immune checkpoint protein, TIGIT.

Address: 257 Simarano Dr Ste 101 Marlborough MASSACHUSETTS 01752

Stay updated.